Respiratory Medicine
Volume 103, Issue 8 , Pages 1136-1142 , August 2009

Pulmonary function testing in patients with pulmonary arterial hypertension

  • Zhi-Cheng Jing

      Affiliations

    • Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
    • Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    • Corresponding Author InformationCorresponding author: Department of Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University, No. 507 Zhengmin Road, Shanghai 200433, China.
    • These authors contributed equally to this article.
    • ,
  • Xi-Qi Xu

      Affiliations

    • Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
    • Aviation Industry Central Hospital, Beijing, China
    • These authors contributed equally to this article.
    • ,
  • David B. Badesch

      Affiliations

    • University of Colorado Health Sciences Center, USA
    • ,
  • Xin Jiang

      Affiliations

    • Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
    • ,
  • Yan Wu

      Affiliations

    • Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    • ,
  • Jin-Ming Liu

      Affiliations

    • Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
    • ,
  • Yong Wang

      Affiliations

    • Beijing Shijitan Hospital, Peking University, Beijing, China
    • ,
  • Lei Pan

      Affiliations

    • Beijing Shijitan Hospital, Peking University, Beijing, China
    • ,
  • Hui-Ping Li

      Affiliations

    • Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
    • ,
  • Jie-Lin Pu

      Affiliations

    • Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    • ,
  • Zhuo-Li Zhang

      Affiliations

    • Peking University First Hospital, Beijing, China
    • ,
  • Yue-Jin Yang

      Affiliations

    • Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Received 22 November 2008 ,Accepted 2 March 2009.

References 

  1. Rubin LJ. Pulmonary arterial hypertension. Proc Am Thorac Soc. 2006;3(1):111–115
  2. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. European Heart Journal. 2004;25:2243–2278
  3. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. NEJM. 1993;328:1732–1739
  4. Peacock AJ. Primary pulmonary hypertension. Thorax. 1999;54:1107–1118
  5. Wessel HU, Kezdi P, Cugell DW. Respiratory and cardiovascular function in patients with severe pulmonary hypertension. Circulation. 1964;29:825–832
  6. Horn M, Ries A, Neveu C, et al. Restrictive ventilatory pattern in precapillary pulmonary hypertension. Am Rev Respir Dis. 1983;128:163–165
  7. Meyer FJ, Ewert R, Hoeper MM, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax. 2002;57:473–476
  8. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension-ACCP evidence-based clinical practice guidelines. Chest. 2004;126:14s–34s
  9. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  10. Quanjer Ph. EGKS: standardized lung function testing. Bull Eur Physiopathol Respir. 1983;19(Suppl. 5):
  11. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with Idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132:373–379
  12. Spiekerkoetter E, Fabel H, Hoeper MM. Effects of inhaled salbutamol in primary pulmonary hypertension. Eur Respir J. 2002;20:524–528
  13. O'Hagen AR, Stilwell PC, Arroliga A. Airway resposiveness to inhaled albuterol in patients with pulmonary hypertension. Clin Pediatr. 1999;38:27–33
  14. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968
  15. Pilette C, Godding V, Kiss R, et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2001;163:185–194
  16. Brand P, App EM, Meyer T, et al. Aerosol bolus dispersion in patients with bronchiolits obliterans after heart–lung and double-lung transplantation. J Aerosol Med. 1998;11:41–53
  17. Cherniack R. Physiologic diagnosis and function in asthma. Clin Chest Med. 1995;16:567–581
  18. Fernandes-Bonetti P, Lupi-Herrera E, Martinez-Guerra ML, et al. Peripheral airways obstruction in idiopathic pulmonary artery hypertension (primary). Chest. 1983;83:732–738
  19. Loscalzo J. Endothelial dysfunction in pulmonary hypertension. NEJM. 1992;327:117–119
  20. Christman B, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacylin metabolites in pulmonary hypertension. NEJM. 1992;327:70–75
  21. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. NEJM. 1995;333:214–221
  22. Martin C, Held HD, Uhlig S. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:128–136
  23. Lee S-D, Shroyer KR, Markham NE, et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101:927–934
  24. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:25s–32s
  25. Sun XG, Hansen JE, Oudiz RJ, et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41:1028–1035
  26. Steenhuis LH, Groen HJ, Koëter GH, et al. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J. 2000;16:276–281
  27. Steen V, Medsger TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 2003 Feb;48(2):516–522

PII: S0954-6111(09)00070-5

doi: 10.1016/j.rmed.2009.03.009

Respiratory Medicine
Volume 103, Issue 8 , Pages 1136-1142 , August 2009

Article Tools

* Image Usage & Resolution